292 related articles for article (PubMed ID: 31503410)
1. GSK-3β inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity.
Li Z; Zhu H; Liu C; Wang Y; Wang D; Liu H; Cao W; Hu Y; Lin Q; Tong C; Lu M; Sachinidis A; Li L; Peng L
J Cell Mol Med; 2019 Nov; 23(11):7796-7809. PubMed ID: 31503410
[TBL] [Abstract][Full Text] [Related]
2. Kcnh2 mediates FAK/AKT-FOXO3A pathway to attenuate sepsis-induced cardiac dysfunction.
Li Z; Meng Y; Liu C; Liu H; Cao W; Tong C; Lu M; Li L; Peng L
Cell Prolif; 2021 Feb; 54(2):e12962. PubMed ID: 33263944
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
5. GSK-3β inhibition confers cardioprotection associated with the restoration of mitochondrial function and suppression of endoplasmic reticulum stress in sevoflurane preconditioned rats following ischemia/reperfusion injury.
Wang Y; Ge C; Chen J; Tang K; Liu J
Perfusion; 2018 Nov; 33(8):679-686. PubMed ID: 29987974
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction.
Wang S; Su X; Xu L; Chang C; Yao Y; Komal S; Cha X; Zang M; Ouyang X; Zhang L; Han S
J Mol Cell Cardiol; 2020 Dec; 149():82-94. PubMed ID: 32991876
[TBL] [Abstract][Full Text] [Related]
7. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
[TBL] [Abstract][Full Text] [Related]
8. Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells.
Li Y; Wang Z; Kong D; Murthy S; Dou QP; Sheng S; Reddy GP; Sarkar FH
J Biol Chem; 2007 Jul; 282(29):21542-50. PubMed ID: 17522055
[TBL] [Abstract][Full Text] [Related]
9. miR-29b-3p protects cardiomyocytes against endotoxin-induced apoptosis and inflammatory response through targeting FOXO3A.
Li Z; Yi N; Chen R; Meng Y; Wang Y; Liu H; Cao W; Hu Y; Gu Y; Tong C; Lu M; Li L; Peng L
Cell Signal; 2020 Oct; 74():109716. PubMed ID: 32707074
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats.
Zhang H; Sha J; Feng X; Hu X; Chen Y; Li B; Fan H
Int Immunopharmacol; 2019 Sep; 74():105717. PubMed ID: 31254953
[TBL] [Abstract][Full Text] [Related]
11. GSKIP protects cardiomyocytes from hypoxia/reoxygenation-induced injury by enhancing Nrf2 activation via GSK-3β inhibition.
Yan L; Cheng G; Yang G
Biochem Biophys Res Commun; 2020 Oct; 532(1):68-75. PubMed ID: 32828530
[TBL] [Abstract][Full Text] [Related]
12. GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury.
Yi L; Huang X; Guo F; Zhou Z; Chang M; Huan J
Front Cell Infect Microbiol; 2017; 7():357. PubMed ID: 28824887
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.
Ren XM; Zuo GF; Wu W; Luo J; Ye P; Chen SL; Hu ZY
PLoS One; 2016; 11(11):e0166740. PubMed ID: 27851811
[TBL] [Abstract][Full Text] [Related]
14. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling.
Jin A; Li B; Li W; Xiao D
Chem Biol Interact; 2019 Dec; 314():108848. PubMed ID: 31610156
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
[TBL] [Abstract][Full Text] [Related]
16. GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.
Zhang H; Wang W; Fang H; Yang Y; Li X; He J; Jiang X; Wang W; Liu S; Hu J; Liu A; Dahmen U; Dirsch O
Mediators Inflamm; 2014; 2014():629507. PubMed ID: 25525303
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK/GSK-3β/Nrf2 signaling pathway.
Duan J; Guan Y; Mu F; Guo C; Zhang E; Yin Y; Wei G; Zhu Y; Cui J; Cao J; Weng Y; Wang Y; Xi M; Wen A
Sci Rep; 2017 Jan; 7():41491. PubMed ID: 28128361
[TBL] [Abstract][Full Text] [Related]
19. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3β pathway independent of PI3K/Akt.
He SF; Jin SY; Wu H; Wang B; Wu YX; Zhang SJ; Irwin MG; Wong TM; Zhang Y
Toxicol Appl Pharmacol; 2015 Nov; 288(3):349-58. PubMed ID: 26296503
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.
Sun D; Shen M; Li J; Li W; Zhang Y; Zhao L; Zhang Z; Yuan Y; Wang H; Cao F
Cardiovasc Diabetol; 2011 Jan; 10():4. PubMed ID: 21232147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
